AE yields 2.53% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, AE + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AE + JNJ for your $10,000?
Adams Resources & Energy, Inc., through its subsidiaries, primarily engages in the marketing, transportation, terminalling, and storage in various crude oil and natural gas basins in the United States. The company operates through three segments: Crude Oil Marketing, Transportation and Storage; Tank truck Transportation of Liquid Chemicals, Pressurized Gases, Asphalt and Dry Bulk; and Pipeline Transportation, Terminalling and Storage of Crude Oil. It purchases crude oil and arranges sales and deliveries to refiners and other customers primarily onshore in Texas, Oklahoma, North Dakota, Michigan, Wyoming, and Louisiana; and owns and operates a fleet of 201 tractor-trailer rigs and maintains approximately 180 pipeline inventory locations or injection stations. The company also transports liquid chemicals, pressurized gases, asphalt, and dry bulk on a for hire basis in the continental United States, and into Canada and Mexico; and operates nineteen truck terminals in Houston, Corpus Christi, Nederland, Freeport, Baton Rouge, St. Rose, Boutte, Sterlington, Jacksonville, Tampa, Atlanta, Augusta, Alabama, North Carolina, Ohio, West Virginia, Arkansas, East St. Louis, Joliet, Louisiana, and the Corpus Christi. In addition, it operates crude oil and condensate pipeline system, which connects the Eagle Ford Basin to the Gulf Coast waterborne market that has a capacity of 450,000 barrels per day. Adams Resources & Energy, Inc. was founded in 1947 and is headquartered in Houston, Texas.
Full AE Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.